• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • All News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | .... 39 Next >
ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

May 18, 2012

Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)

May 17, 2012

Study Reports Catheter Ablation Superior to Drug Therapy as First-Line Treatment

May 11, 2012

Biosense Webster Announces Launch of the THERMOCOOL® SF NAV Catheter With Curve Visualization

May 10, 2012

The Aveeno Brand and The Skin Cancer Foundation Challenge Melanoma Epidemic with 5th Annual Road to Healthy Skin Tour

May 09, 2012

Biosense Webster Collaborates to Bring Innovative Solutions to Electrophysiologists Around the World

May 09, 2012

< Prev | | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | .... 39 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • All News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | .... 39 Next >
ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

May 18, 2012

Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)

May 17, 2012

Study Reports Catheter Ablation Superior to Drug Therapy as First-Line Treatment

May 11, 2012

Biosense Webster Announces Launch of the THERMOCOOL® SF NAV Catheter With Curve Visualization

May 10, 2012

The Aveeno Brand and The Skin Cancer Foundation Challenge Melanoma Epidemic with 5th Annual Road to Healthy Skin Tour

May 09, 2012

Biosense Webster Collaborates to Bring Innovative Solutions to Electrophysiologists Around the World

May 09, 2012

< Prev | | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | .... 39 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •